A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Becton Dickinson & CO stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 76,487 shares of BDX stock, worth $17.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
76,487
Previous 81,012 5.59%
Holding current value
$17.4 Million
Previous $18.9 Million 2.6%
% of portfolio
0.1%
Previous 0.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$221.47 - $242.41 $1 Million - $1.1 Million
-4,525 Reduced 5.59%
76,487 $18.4 Million
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $1.49 Million - $1.62 Million
-6,600 Reduced 7.53%
81,012 $18.9 Million
Q1 2024

May 15, 2024

BUY
$233.45 - $247.73 $20.5 Million - $21.7 Million
87,612 New
87,612 $21.5 Billion
Q4 2023

Aug 14, 2024

BUY
$232.24 - $267.23 $370,887 - $426,766
1,597 Added 2.17%
75,131 $18.3 Billion
Q3 2023

Aug 14, 2024

SELL
$254.9 - $283.59 $1.48 Million - $1.65 Million
-5,802 Reduced 7.31%
73,534 $19 Billion
Q2 2023

Aug 14, 2024

SELL
$238.39 - $265.32 $1.15 Million - $1.28 Million
-4,839 Reduced 5.75%
79,336 $20.9 Billion
Q1 2023

Aug 14, 2024

BUY
$229.71 - $259.35 $291,961 - $329,633
1,271 Added 1.53%
84,175 $20.8 Billion
Q4 2022

Aug 14, 2024

BUY
$218.29 - $256.91 $161,752 - $190,370
741 Added 0.9%
82,904 $21.1 Billion
Q3 2022

Aug 14, 2024

SELL
$51.03 - $264.23 $158,550 - $820,962
-3,107 Reduced 3.64%
82,163 $18.3 Billion
Q2 2022

Aug 14, 2024

SELL
$234.74 - $275.42 $426,053 - $499,887
-1,815 Reduced 2.08%
85,270 $21 Billion
Q1 2022

Aug 14, 2024

BUY
$243.64 - $270.48 $1.48 Million - $1.64 Million
6,073 Added 7.5%
87,085 $23.2 Billion
Q4 2021

Aug 30, 2024

BUY
$230.08 - $250.94 $6.33 Million - $6.91 Million
27,525 Added 37.0%
101,918 $25.6 Billion
Q3 2021

Aug 30, 2024

BUY
$232.72 - $256.47 $816,614 - $899,953
3,509 Added 4.95%
74,393 $18.3 Billion
Q2 2021

Aug 30, 2024

SELL
$232.65 - $254.58 $2.36 Million - $2.58 Million
-10,128 Reduced 12.5%
70,884 $17.2 Billion
Q1 2021

Aug 30, 2024

BUY
$232.09 - $256.88 $11.2 Million - $12.4 Million
48,189 Added 152.27%
79,837 $19.4 Billion
Q4 2020

Aug 30, 2024

BUY
$221.92 - $245.94 $472,467 - $523,606
2,129 Added 7.21%
31,648 $7.92 Billion
Q3 2020

Aug 30, 2024

BUY
$215.77 - $276.76 $186,209 - $238,843
863 Added 3.01%
29,519 $6.87 Billion
Q2 2020

Aug 30, 2024

BUY
$219.9 - $263.41 $135,898 - $162,787
618 Added 2.2%
28,656 $6.86 Billion
Q1 2020

Aug 30, 2024

BUY
$195.69 - $279.01 $113,304 - $161,546
579 Added 2.11%
28,038 $6.44 Billion
Q4 2019

Aug 30, 2024

SELL
$236.45 - $266.82 $90,560 - $102,192
-383 Reduced 1.38%
27,459 $7.47 Billion
Q3 2019

Aug 30, 2024

BUY
$230.58 - $256.08 $49,113 - $54,545
213 Added 0.77%
27,842 $7.04 Billion
Q2 2019

Aug 30, 2024

SELL
$217.4 - $246.08 $4.09 Million - $4.63 Million
-18,825 Reduced 40.52%
27,629 $6.96 Billion
Q1 2019

Aug 30, 2024

BUY
$206.05 - $248.17 $68,202 - $82,144
331 Added 0.72%
46,454 $11.6 Billion
Q4 2018

Aug 30, 2024

SELL
$204.73 - $257.93 $7.14 Million - $9 Million
-34,889 Reduced 43.07%
46,123 $10.4 Billion
Q3 2018

Aug 30, 2024

BUY
$233.07 - $256.0 $123,993 - $136,192
532 Added 1.18%
45,733 $11.9 Billion
Q2 2018

Aug 30, 2024

BUY
$208.1 - $233.85 $237,858 - $267,290
1,143 Added 2.59%
45,201 $10.8 Billion
Q1 2018

Aug 30, 2024

BUY
$205.46 - $240.27 $210,801 - $246,517
1,026 Added 2.38%
44,058 $9.55 Billion
Q4 2017

Aug 30, 2024

BUY
$189.0 - $222.64 $99,414 - $117,108
526 Added 1.24%
43,032 $9.21 Billion
Q3 2017

Aug 30, 2024

BUY
$186.89 - $198.9 $61,860 - $65,835
331 Added 0.78%
42,506 $8.33 Billion
Q2 2017

Aug 30, 2024

SELL
N/A
-39,574 Reduced 48.41%
42,175 $8.23 Billion
Q1 2017

Aug 30, 2024

BUY
N/A
737
81,749 $15 Billion

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.